Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAMILLA: T-DM1 in HER2+ Advanced Breast Cancer
NCT01702571Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2012
- Primary completion
- Jul 2020
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 43
01
Overview
A Phase 3 trial of trastuzumab emtansine in breast cancer, sponsored by Roche. Started Nov 2012; status: completed.
02
Drugs
trastuzumab emtansine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01702571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702571.